Leading NGS QC Software is integrated into their Philips IntelliSpace Genomics Platform
MILFORD, MA, UNITED STATES - Apr 17, 2018 -
SeraCare Life Sciences
has partnered with
NAVICAN
, an Intermountain Healthcare company, and Royal Philips on the integration of SeraCares leading clinical NGS QC solution to support the roll out of NAVICANs TheraMap Precision Cancer Care services. The integrated solution connects SeraCares
iQTM NGS QC Management software
to the Philips IntelliSpace Genomics Platform to automate tracking of all critical genomics workflow QC parameters necessary for monitoring, trending, and reporting on the performance of the TheraMap clinical NGS assay.
SeraCares iQ NGS QC Management solution leverages the industrys broadest selection of quantitative multiplexed DNA and RNA reference materials with a powerful QC tracking and reporting software solution. Clinical labs implementing powerful new NGS-based diagnostics as part of their precision medicine programs recognize the challenges for demonstrating compliance, benchmarking performance, and troubleshooting quickly and effectively. These critical activities are multiplied by the numerous QC metrics that must be tracked in each workflow step and the many genes and variant types validated in the assay. Successfully performing these activities can be a resource drain on labs, even those equipped with bioinformatics teams. Moreover, labs are already investing in several software packages that simplify access to their data sets but lack an overarching system to present the data in context to answer key operational and quality questions. The iQ NGS QC Management solution is a best-in-class tool that works with existing bioinformatics and LIMS infrastructure and can scale as the labs needs grow and change.
NAVICAN is excited to add SeraCare Life Sciences to the list of industry leaders weve partnered with as we launch our TheraMap precision cancer service, said Keith Gligorich, Laboratory Operations Director at NAVICAN. Incorporating the iQ NGS QC Management solution into our laboratory alongside the Phillips IntelliSpace Genomics clinical-grade platform will help us track all of our QC metrics easily and seamlessly. We are now able to generate reports and track assay performance from our clinical samples with Philips and standardized reference materials with SeraCare.
We are so pleased to be working with the visionary leadership at NAVICAN as they adopt a scalable, best-in-class QC platform for their TheraMap Precision Cancer Service. It is no longer sufficient to run just any remnant patient sample as a positive control with todays comprehensive clinical NGS assays, said Trevor Brown, VP, Clinical Genomics at SeraCare Life Sciences. Labs need to closely monitor all aspects of their QC metrics throughout the entire workflow with quantitative multiplexed standards, and track performance over time. The iQ NGS QC Management solution is the only tool designed specifically for NGS-based clinical workflows while easily integrating into existing bioinformatics and LIMS infrastructure.
Learn more about best-in-class QC solutions at
www.seracare.com/qc
About SeraCare Life Sciences, Inc.
SeraCare enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result. Our innovative tools and technologies not only provide assurance of the safe, effective, and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data from precision diagnostics. Our portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents. For more information, please visit
www.seracare.com
and follow SeraCare on Twitter (
@SeraCare
).
About NAVICAN
NAVICAN, an Intermountain Healthcare company, offers Precision Cancer Care to transform and advance cancer care for patients everywhere that advanced therapies are available. NAVICAN offers expert therapy recommendations and experienced navigators to help patients and their caregivers get the precision therapy they need as soon as possible. NAVICAN uses TheraMap, a comprehensive end-to-end service to help oncologists and patients harness the power of precision medicine to improve outcomes and reduce cost. Developed through years of experience and clinical best practices of Intermountain Healthcare, TheraMap combines state-of-the-art next generation sequencing technology, clinical expertise and a molecular tumor board to provide a treatment recommendation. For more information, please visit us at
www.NAVICAN.com
.
Company Contact:
Heather DelCarpini
SeraCare Life Sciences, Inc.
508.244.6429
hdelcarpini@seracare.com
www.seracare.com
Company Contact:
Alaine Gordon
NAVICAN
858.717.5329
alaine.gordon@navican.com
www.navican.com